First Trust Nyse Arca Biotech Etf logo

First Trust Nyse Arca Biotech Etf (FBT) Technical Analysis

$176.460.57%

Market is closed - opens 7 PM, 17 Sep 2025

Insights

  • First Trust Nyse Arca Biotech Etf is currently in a neutral trading position according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for First Trust Nyse Arca Biotech Etf stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, First Trust Nyse Arca Biotech Etf stock is in a uptrend ↗️
  • Based on analysis of the Pivot Points, the current market trend for First Trust Nyse Arca Biotech Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
54.05
Neutral
Stochastic
48.79, 64.15
Neutral
Ultimate Oscillator
48.76
Neutral
Stochastic Relative Strength Index
18.35, 34.77
Neutral
Moving Average Convergence Divergence
2.35, 2.43
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
175.85
Buy
20
174.34
Buy
50
168.85
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
175.59
Buy
20
173.89
Buy
50
169.86
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
175.81
Neutral
20
174.19
Neutral
50
167.86
Buy

Double Exponential Moving Average

Period (Days)

Value

Action

10
176.97
Sell
20
177.11
Buy
50
174.99
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
176.61
Sell
20
177.47
Buy
50
176.77
Buy

Pivot

Pivot

Value

Resistance L3
183.85
Resistance L2
181.29
Resistance L1
179.98
Pivot Point
177.42
Support L1
176.12
Support L2
173.56
Support L3
172.25

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.